The FDA issued Import Alert 25-02 for morel mushrooms imported from a company in France on May 23, 2022 because, in the past, shipments of canned and dried mushrooms were detained because of the presence of Gyromitra esculenta, or false morel. This species can produce monomethylhydrazine (MMH), which is a toxin that can cause severe gastrointestinal illnesses and, in some cases, death. The Center for Food Safety and Applied Nutrition (CFSAN) identified another species, Verpa bohemica, or early morel, which can also cause illness in some people. All morel mushrooms imported from that company and false morel mushrooms, also imported from that company, in the form of fresh, canned, and dried, are subject to this import alert until further notice. Morel mushrooms are a distinctive … [Read more...]
FDA Report on 2022 Cantaloupe Salmonella Outbreak
The FDA has issued a report on the 2022 cantaloupe Salmonella outbreak that sickened at least 88 people and hospitalized 32. No specific brand was named, and no grower was named. The cantaloupe was grown in southwest Indiana in the summer of 2022. There is quite a long history of food poisoning outbreaks linked to cantaloupe. The case count for that outbreak was: Georgia (1), Illinois (5), Indiana (17), Iowa (39), Kentucky (3), Michigan (3), Minnesota (4), Missouri (2), Ohio (3), South Carolina (1), and Wisconsin (10). The last illness onset date was September 13, 2022. The FDA inspected three farms in Indiana, their common packinghouse, and public lands near the farms. Environmental samples positive for Salmonella were found at each location, but none of the isolates matched … [Read more...]
FDA Strategy to Increase Resilience of Infant Formula Market
The FDA has released a national strategy to increase the resilience of the infant formula market in the United States. Last year, cronobacter illnesses among some infants led to the inspection of Abbott Nutrition's Sturgis, Michigan plant where problems were found, including multiple swabs indicating cronobacter contamination. Many recalls were issued and the plant was closed, which threw the infant formula supply in the United States into chaos. While there was not a match between the contamination in the Abbott plant and the sick infants, the situation highlighted how brittle the supply of powdered infant formula is in this country. In 2022, the Food and Drug Omnibus Reform Act directed the FDA to develop this strategy to help keep the market for this product stable. FDA … [Read more...]
FDA Completes Second Pre-Market Consultation for Cultured Food
The FDA has completed its second pre-market consultation for human food made using animal cell culture technology. The information was submitted to the FDA from GOOD Meat, Inc. The firm is using animal cell culture technology to take living cells from chickens and grows the cells in a controlled environment to make cultured animal cell food. This consultation is not an approval process. It means that after the government has evaluated the data and information that was shared by the firm, the FDA has no further questions at this time about the firm's safety conclusion. GOOD Meat says that its products are meat made from cells of animals instead of slaughter. During this consultation, the FDA evaluated the company's production process and the cultured cell material that was made in … [Read more...]
FDA Calls For Enhanced Safety Steps in Powdered Infant Formula
The FDA is calling for enhanced safety steps in powdered infant formula in the wake of the cronobacter crisis in that industry in 2022. Back then, Abbott Nutrition had to close their plant in Sturgis, Michigan that manufactured that formula after cronobacter contamination was found. The whole issue started when four infants were sickened and two died in 2021 and 2022. Those infants were fed powdered infant formula made by Abbott Nutrition. Although cronobacter was found in the Abbott facility, the FDA did not find a connection between the illnesses and the facility. In addition, the FDA found insanitary conditions at that facility. The Abbott facility closed for months after the contamination was found, causing a severe shortage in the infant formula products they made. The FDA … [Read more...]
FDA Advises Labeling of Plant-Based Milk Alternatives
The FDA is advising companies about labeling of plant-based milk alternatives, since they have different nutrient compositions than cow's milk. These recommendations will make it clear to consumers about these differences so they can make informed decisions. Plant-based products are made from hazelnuts, walnuts, coconuts, cashews, almonds, sesame seed, flax seed, hemp seed, rice, oats, and legumes, including soy. The FDA recommends that these products are labeled with "milk" in their names, such as "almond milk." They would also like to see a voluntary nutrient statement that shows consumers how the product compares with cow's ilk. If the product does not include the word "milk" as part of it name, but instead uses a word like "drink" and doesn't make any claims comparing the … [Read more...]
FDA on Wild Harvest Oysters Salmonella Outbreak in FL GA AL
FDA is weighing in on the wild harvest oysters Salmonella outbreak that has sickened at least eight people in Florida, Georgia, and Alabama. Any retailers and restaurants that have received wild harvest oysters from harvest area FL-3012 in Cedar Key, Florida, harvested between December 16, 2022 and February 24, 2023 should be discarded. Consumers who bought those oysters at retail in those three states should also discard them. The FDA says it's possible that other states may have received the oysters. So if you purchased raw oysters, check the packaging to see if they were harvested in that area. A Salmonella outbreak linked to those oysters has been detected by the state health departments in Florida, Georgia, and Alabama. Eight cases are linked to this outbreak. We do not … [Read more...]